Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Equity Ratio: 2020-2024

Historic Equity Ratio for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to 0.02.

  • Oncology Institute's Equity Ratio fell 18682.05% to 0.08 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 19278.04%. This contributed to the annual value of 0.02 for FY2024, which is 9237.54% down from last year.
  • Oncology Institute's Equity Ratio amounted to 0.02 in FY2024, which was down 9237.54% from 0.27 recorded in FY2023.
  • Oncology Institute's 5-year Equity Ratio high stood at 0.51 for FY2021, and its period low was 0.02 during FY2024.
  • Its 5-year average for Equity Ratio is 0.34, with a median of 0.43 in 2020.
  • Per our database at Business Quant, Oncology Institute's Equity Ratio soared by 1968.33% in 2021 and then tumbled by 9237.54% in 2024.
  • Oncology Institute's Equity Ratio (Annual) stood at 0.43 in 2020, then grew by 19.68% to 0.51 in 2021, then dropped by 8.06% to 0.47 in 2022, then plummeted by 42.1% to 0.27 in 2023, then plummeted by 92.38% to 0.02 in 2024.
  • Its Equity Ratio was 0.02 in FY2024, compared to 0.27 in FY2023 and 0.47 in FY2022.